title: Toxic epidermal necrolysis as a complication of treatment with voriconazole.
abstract: An 81-year-old female received voriconazole in a 7-day treatment course for a symptomatic Candida krusei urinary tract infection. Four days after the last dose, she developed toxic epidermal necrolysis. She was treated with intravenous immunoglobulin, and her symptoms promptly resolved.
authors.affiliation: Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA. dhuang1@bcm.tmc.edu
authors.forename: David B
authors.initials: DB
authors.lastname: Huang
authors.forename: Jashin J
authors.initials: JJ
authors.lastname: Wu
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Lahart
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000935:Antifungal Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D011743:Pyrimidines / Q000009:adverse effects*; D013262:Stevens-Johnson Syndrome / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D014230:Triazoles / Q000009:adverse effects*; D065819:Voriconazole
chemical_list: D000935:Antifungal Agents; D016756:Immunoglobulins, Intravenous; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole